Gabriella Chauca Strand

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 15

Top Topics

Randomized Controlled Trial

Artificial Intelligence

Top Venues

European journal of epidemiology

JNCI cancer spectrum

Clinical drug investigation

This page only lists publications with an associated author ORCID identifier.

Publications

Gabriella Chauca Strand, Ulf Strömberg, Anna Forsberg, Carl Bonander
Impact of organised colorectal cancer screening on age-specific population incidences: evidence from a quasi-experimental study in Sweden. European journal of epidemiology 39 (1) (2024)
Gabriella Chauca Strand, Ulf Strömberg, Anna Forsberg, Carl Bonander
Impact of organised colorectal cancer screening on age-specific population incidences: evidence from a quasi-experimental study in Sweden. European journal of epidemiology 39 (1) (2024)
Gabriella Chauca Strand, Ulf Strömberg, Anna Forsberg, Carl Bonander
Impact of organised colorectal cancer screening on age-specific population incidences: evidence from a quasi-experimental study in Sweden. European journal of epidemiology 39 (1) (2024)
Gabriella Chauca Strand, Ulf Strömberg, Anna Forsberg, Carl Bonander
Impact of organised colorectal cancer screening on age-specific population incidences: evidence from a quasi-experimental study in Sweden. European journal of epidemiology 39 (1) (2024)
Gabriella Chauca Strand, Ulf Strömberg, Anna Forsberg, Carl Bonander
Impact of organised colorectal cancer screening on age-specific population incidences: evidence from a quasi-experimental study in Sweden. European journal of epidemiology 39 (1) (2024)
Gabriella Chauca Strand, Ulf Strömberg, Anna Forsberg, Carl Bonander
Impact of organised colorectal cancer screening on age-specific population incidences: evidence from a quasi-experimental study in Sweden. European journal of epidemiology (2024)
Carl Bonander, Marcus Westerberg, Gabriella Chauca Strand, Anna Forsberg, Ulf Strömberg
Colorectal cancer screening with fecal immunochemical testing or primary colonoscopy: inequities in diagnostic yield. JNCI cancer spectrum 8 (3) (2024)
Carl Bonander, Marcus Westerberg, Gabriella Chauca Strand, Anna Forsberg, Ulf Strömberg
Colorectal cancer screening with fecal immunochemical testing or primary colonoscopy: inequities in diagnostic yield. JNCI cancer spectrum 8 (3) (2024)
Gabriella Chauca Strand, Ulf Strömberg, Anna Forsberg, Carl Bonander
Impact of organised colorectal cancer screening on age-specific population incidences: evidence from a quasi-experimental study in Sweden. European journal of epidemiology 39 (1) (2024)
Gabriella Chauca Strand, Ulf Strömberg, Anna Forsberg, Carl Bonander
Correction: Impact of organised colorectal cancer screening on age-specific population incidences: evidence from a quasi-experimental study in Sweden. European journal of epidemiology (2024)
Carl Bonander, Marcus Westerberg, Gabriella Chauca Strand, Anna Forsberg, Ulf Strömberg
Colorectal cancer screening with fecal immunochemical testing or primary colonoscopy: inequities in diagnostic yield. JNCI cancer spectrum 8 (3) (2024)
Carl Bonander, Marcus Westerberg, Gabriella Chauca Strand, Anna Forsberg, Ulf Strömberg
Colorectal cancer screening with fecal immunochemical testing or primary colonoscopy: inequities in diagnostic yield. JNCI cancer spectrum 8 (3) (2024)
Gabriella Chauca Strand, Ulf Strömberg, Anna Forsberg, Carl Bonander
Impact of organised colorectal cancer screening on age-specific population incidences: evidence from a quasi-experimental study in Sweden. European journal of epidemiology 39 (1) (2024)
Gabriella Chauca Strand, Ulf Strömberg, Anna Forsberg, Carl Bonander
Impact of organised colorectal cancer screening on age-specific population incidences: evidence from a quasi-experimental study in Sweden. European journal of epidemiology 39 (1) (2024)
Gabriella Chauca Strand, Naimi Johansson, Niklas Jakobsson, Carl Bonander, Mikael Svensson
Cancer Drugs Reimbursed with Limited Evidence on Overall Survival and Quality of Life: Do Follow-Up Studies Confirm Patient Benefits? Clinical drug investigation (2023)